" ( ) "

³ ( )

 (0)

 (0)

    
  1 / 1 |   | | viewdetails | |  
 # 106115
15- ֲ ² ' ˲
      (uk)     (ru)     (en)      
( 20 .)  䳺
(11) 106115 (51)
A61K 39/09 (2006.01)
(24) 25.07.2014
(21) a201210582 (22) 03.02.2011
(31) 61/302,726
(32) 09.02.2010
(33) US
(41) 10.10.2012, . 19
(46) 25.07.2014, . 14
(56) WO 2006110381 A1, 19.10.2006.
CN 101590224 A, 02.12.2009.
WO 2009000826 A1, 31.12.2008.
NURKKA ANU ET AL: "IMMUNOGENICITY AND SAFETY OF THE ELEVEN VALENT PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN D CONJUGATE VACCINE IN INFANTS", THE PEDIATRIC INFECTIOUS DISEASE JOURNAL, LIPPINCOTT WILLIAMS & WILKINS, US, vol. 23, no. 11, 1 November 2004 (2004-11-01), pages 1008-1014.
SCOTT ET AL: "Phase 1 trial of a 13-valent pneumococcal conjugate vaccine in healthy adults", VACCINE, ELSEVIER LTD, GB, vol. 25, no. 33, 24 July 2007 (2007-07-24) , pages 6164-6166. PILISHVILI TAMARA ET AL: "Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine.", THE JOURNAL OF INFECTIOUS DISEASES 1 JAN 2010, vol. 201, no. 1, 1 January 2010 (2010-01-01), pages 32-41.
YILDIRIM I ET AL: "Serotype specific invasive capacity and persistent reduction in invasive pneumococcal disease", VACCINE, ELSEVIER LTD, GB, vol. 29, no. 2, 16 December 2010 (2010-12-16), pages 283-288.
BRYANT KRISTINA A ET AL: "Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine.", PEDIATRICS MAY 2010, vol. 125, no. 5, May 2010 (2010-05), pages 866-875.
JULIE M SKINNER ET AL: "Pre-clinical evaluation of a 15-valent pneumococcal conjugate vaccine (PCV15-CRM197) in an infant-rhesus monkey immunogenicity model", VACCINE, ELSEVIER LTD, GB, vol. 29, no. 48, 1 October 2011 (2011-10-01), pages 8870-8876.
US 2009010959 A1, 08.01.2009.
US 2009035326 A1, 05.02.2009.
(85) 07.09.2012
(86) PCT/US2011/023526, 03.02.2011
(71) . (US )
...................................................................................................................................................................
. (US )
...................................................................................................................................................................
MERCK SHARP & DOHME CORP. (US )
(72) . (US ); . (US ); . (US ); . (US )
...................................................................................................................................................................
. (US ); , . (US ); . (US ); . (US )
...................................................................................................................................................................
Caulfield, Michael, J. (US ); Ahl, Patrick, L. (US ); Blue, Jeffrey, T. (US ); Cannon, Jayme, L. (US )
(73) ., 126 East Lincoln Avenue, Rahway, NJ 07065-0907, United States of America (US )
...................................................................................................................................................................
. (US )
...................................................................................................................................................................
MERCK SHARP & DOHME CORP. (US )
(74) ͳ
(98) ͳ
. . , 25, . 3, . -135, 01135
(UA)
(54) 15- ֲ ² ' ˲
...................................................................................................................................................................
15-VALENT PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATE VACCINE COMPOSITION
...................................................................................................................................................................
15-
(57)
   
 
1.21511411667